Use of Epidemiology Surge Support to Enhance Robustness and Expand Capacity of SARS-CoV-2 Pandemic Response, South Africa

Emerg Infect Dis. 2022 Dec;28(13):S177-S180. doi: 10.3201/eid2813.212522.

Abstract

As COVID-19 cases increased during the first weeks of the pandemic in South Africa, the National Institute of Communicable Diseases requested assistance with epidemiologic and surveillance expertise from the US Centers for Disease Control and Prevention South Africa. By leveraging its existing relationship with the National Institute of Communicable Diseases for >2 months, the US Centers for Disease Control and Prevention South Africa supported data capture and file organization, data quality reviews, data analytics, laboratory strengthening, and the development and review of COVID-19 guidance This case study provides an account of the resources and the technical, logistical, and organizational capacity leveraged to support a rapid response to the COVID-19 pandemic in South Africa.

Keywords: COVID-19; SARS-CoV-2; South Africa; coronavirus disease; epidemiologic capacity; respiratory infections; severe acute respiratory syndrome coronavirus 2; vaccine-preventable diseases; viruses; zoonoses.

Publication types

  • Review

MeSH terms

  • COVID-19* / epidemiology
  • Humans
  • Laboratories
  • Pandemics* / prevention & control
  • SARS-CoV-2
  • South Africa / epidemiology
  • United States